Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2023-06-20 00:00:00 ET · period of report 2023-06-16 · accession 0001104659-23-072614 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-20 | 2023-06-16 | NVCT | Mosseri Marlio Charles | 10% | P - Purchase | $17.75 | +12.7K | 2.42M | +0.5% | +$225.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-16 | P | A | 12,700 | $17.75 | 2,425,000 | D | — | — |